The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
De novo mutations in schizophrenia implicate synaptic networks
Open accessAbstract
Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one or a few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-d-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While most children with SCN2A variants fit into one of these three categories, there are some exceptions, including epileptic encephalopathy with choreoathetoid movements [26,27], benign infantile seizures with late-onset episodic ataxia [28–31], childhood-onset epileptic encephalopathy [32], and schizophrenia [33,34].”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [33]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The human NDR2 gene (STK38l) has been identified as a susceptibility gene for neurodevelopmental disorders, intellectual disability (Madencioglu et al. 2021; Firth et al. 2009), and autism spectrum disorder (Fromer et al. 2014).”
From The Serine/Threonine Kinase NDR2 Regulates Integrin Signaling, Synapse Formation, and Synaptic Plasticity in the Hippocampus (2025) · cites this paper as Fromer et al. 2014
Experimental — accuracy not yet measuredIn the citing paper
“We tested for and found that genes in which rare variants increase risk of ASD and DD32,33 are also enriched for schizophrenia common variant associations.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“We controlled for a set of 10,360 genes with detectable expression in brain tissue measured as Fragments Per Kilobase of transcript per Million mapped reads (FPKM)32 to detect synaptic signals above signals simply reflecting the property of brain expression.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [80]
In the citing paper
“Protein-truncating variants (PTVs) are among the most interpretable associations as they suggest that the effect on disease most commonly tracks with decreasing expression of the gene18.”
From Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) · cites this paper as [18]
In the citing paper
“This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“A strong and consistent finding in exome-sequencing studies of schizophrenia involves an excess of variants in genes whose mRNAs are bound by the fragile X mental retardation protein (FMRP)9,12,27.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“we identified an ultra-rare splice donor variant in TAF1312, an ultra-rare nonsense variant in SETD1A16,17, and a single ultra-rare nonsense variant in NRXN1, a gene in which exonic deletions associate with schizophrenia18.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia12 and 0.156 (95% CI 0.139-0.174) for unaffected individuals13.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“Estimated 3rd and 5th principal components corresponded to previously observed Finnish and Northern-Southern Sweden clines12 (Supplementary Fig. 12d)”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Rate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Self-citationDiagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,004
Low-Level Brain Somatic Mutations Are Implicated in Schizophrenia
Kim, M.-H., Kim, I. B., Lee, J., Cha, D. H., Park, S. M., Kim, J. H., Kim, R., Park, J. S., An, Y., Kim, K., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.014 · Cited by 28
Loviglio, M. N., Beck, C. R., White, J. J., Leleu, M., Harel, T., Guex, N., Niknejad, A., Bi, W., Chen, E. S., Crespo, I., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0359-z · Cited by 30
Systems-level analysis of risk genes reveals the modular nature of schizophrenia
Liu, J., Li, M., Luo, X., & Su, B. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.015 · Cited by 28
Rare variants and de novo variants in mesial temporal lobe epilepsy with hippocampal sclerosis
Wong, J., Gui, H., Kwok, M., Ng, P. W., Lui, C. H. T., Baum, L., Sham, P. C., Kwan, P., & Cherny, S. S. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000245 · Cited by 28
Understanding the association between advanced paternal age and schizophrenia and bipolar disorder
Weiser, M., Fenchel, D., Frenkel, O., Fruchter, E., Burshtein, S., Yehuda, A. B., Yoffe, R., Bergman-Levy, T., Reichenberg, A., Davidson, M., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719000242 · Cited by 28
Kevlar: A Mapping-Free Framework for Accurate Discovery of De Novo Variants
Standage, D., Brown, C. T., & Hormozdiari, F. (2019) · iScience · doi:10.1016/j.isci.2019.07.032 · Cited by 28
Jacobsen, K. K., Kleppe, R., Johansson, S., Zayats, T., & Haavik, J. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32339 · Cited by 28
Noureddine, M., Mikolajek, H., Morgan, N. V., Denning, C. N., Loughna, S., Gehmlich, K., & Mohammed, F. (2025) · The Journal of General Physiology · doi:10.1085/jgp.202413684 · Cited by 27
Classification of Behaviorally Defined Disorders: Biology Versus the DSM
Rapin, I. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2127-5 · Cited by 27
Kranz, T. M., Berns, A., Shields, J., Rothman, K., Walsh‐Messinger, J., Goetz, R. R., Chao, M. V., & Malaspina, D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.008 · Cited by 27
Brain transcriptome atlases: a computational perspective
Mahfouz, A. E., Huisman, S. M. H., Lelieveldt, B. P. F., & Reinders, M. J. T. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1338-2 · Cited by 27
Hao, X., Chen, X., Zhang, Y., Chen, P., Wei, C., Shi, W., & Gao, H. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01512-7 · Cited by 27
Impact of maternal immune activation on dendritic spine development
Pękała, M., Doliwa, M., & Kalita, K. B. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22804 · Cited by 27
A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression
Li, Y., Ma, C., Li, W., Yang, Y., Li, X., Liu, J., Wang, J., Li, S., Liu, Y., Li, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01125-x · Cited by 27
de Bartolomeis, A., Ciccarelli, M., Simone, G. D., Mazza, B., Barone, A., & Vellucci, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065945 · Cited by 29
Chromosomal microarray analysis—a routine clinical genetic test for patients with schizophrenia
Baker, K., Costain, G., Fung, W. L. A., & Bassett, A. S. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70308-6 · Cited by 27
Györffy, B. A., Gulyássy, P., Gellén, B., Völgyi, K., Madarasi, D., Kis, V., Ozohanics, O., Papp, I., Kovács, P., Lübec, G., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.002 · Cited by 27
Genetics implicate common mechanisms in autism and schizophrenia: synaptic activity and immunity
Liu, X., Li, Z., Fan, C., Zhang, D., & Chen, J. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104487 · Cited by 27
An interaction network of mental disorder proteins in neural stem cells
Moen, M. J., Adams, H. H. H., Brandsma, J. H., Dekkers, D. H. W., Akinci, U., Karkampouna, S., Quevedo, M., Kockx, C. E. M., Özgür, Z., van IJcken, W. F. J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.52 · Cited by 27
Han, M.-R., Han, K.-M., Kim, A., Kang, W., Kang, Y., Kang, J. C., Won, E., Tae, W., Cho, Y., & Ham, B. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.028 · Cited by 27
Dynamic scaffolds for neuronal signaling: in silico analysis of the TANC protein family
Gasparini, A., Tosatto, S. C. E., Murgia, A., & Leonardi, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-05748-5 · Cited by 27
Understanding the genetic liability to schizophrenia through the neuroepigenome
Fullard, J. F., Halene, T. B., Giambartolomei, C., Haroutunian, V. H., Akbarian, S., & Roussos, P. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.039 · Cited by 26
Self-citationLiu, J., Li, S., Li, X., Li, W., Yang, Y., Guo, S., Lv, L., Xiao, X., Yao, Y., Guan, F., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02039-9 · Cited by 26
de Arce, K. P., Ribic, A., Chowdhury, D., Watters, K. E., Thompson, G. J., Sanganahalli, B. G., Lippard, E., Rohlmann, A., Strittmatter, S. M., Missler, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36042-w · Cited by 26
The role of Pcdh10 in neurological disease and cancer
Zhen, Y., Pavez, M., & Li, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04743-w · Cited by 26
Chen, Y., Wang, X., Xiao, B., Luo, Z., & Long, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03442-4 · Cited by 26
Cross-Disorder Comparison of Four Neuropsychiatric CNV Loci
Moreno‐De‐Luca, D., Moreno-De-Luca, A., Cubells, J. F., & Sanders, S. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0045-7 · Cited by 26
Identification of somatic mutations in monozygotic twins discordant for psychiatric disorders
Nishioka, M., Bundo, M., Ueda, J., Yoshikawa, A., Nishimura, F., Sasaki, T., Kakiuchi, C., Kasai, K., Kato, T., & Iwamoto, K. (2018) · Schizophrenia · doi:10.1038/s41537-018-0049-5 · Cited by 26
Huo, C., Liu, X., Zhao, J., Zhao, T., Huang, H., & Ye, H. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.030 · Cited by 26
Convergent Evidence That ZNF804A Is a Regulator of Pre-messenger RNA Processing and Gene Expression
Chapman, R. M., Tinsley, C. L., Hill, M., Forrest, M. P., Tansey, K. E., Pardiñas, A. F., Rees, E., Doyle, A. M., Wilkinson, L. S., Owen, M. J., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby183 · Cited by 26
Self-citationBobsin, K., & Kreienkamp, H. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13428 · Cited by 26
Genomic approaches to the assessment of human spina bifida risk
Ross, M. E., Mason, C. E., & Finnell, R. H. (2016) · Birth Defects Research · doi:10.1002/bdra.23592 · Cited by 26
Molecular subtyping and improved treatment of neurodevelopmental disease
Stessman, H. A. F., Turner, T. N., & Eichler, E. E. (2016) · Genome Medicine · doi:10.1186/s13073-016-0278-z · Cited by 25
Magri, C., Giacopuzzi, E., Via, L. L., Bonini, D., Ravasio, V., Elhussiny, M. E. A., Orizio, F., Gangemi, F., Valsecchi, P., Bresciani, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33924-8 · Cited by 25
Molecular architecture of postsynaptic Interactomes
Wilkinson, B., & Coba, M. P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109782 · Cited by 25
Hathy, E., Szabó, E., Varga, N., Erdei, Z., Tordai, C., Czehlár, B., Baradits, M., Jezsó, B., Koller, J., Nagy, L., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01980-5 · Cited by 25
Petropavlovskiy, A. A., Kogut, J. A., Leekha, A., Townsend, C. A., & Sanders, S. S. (2021) · Neuronal Signaling · doi:10.1042/ns20210005 · Cited by 26
Shepard, N., Báez-Nieto, D., Iqbal, S., Kurganov, E., Budnik, N., Campbell, A. J., Pan, J. Q., Sheng, M., & Farsi, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-53102-3 · Cited by 25
Biological pathways and networks implicated in psychiatric disorders
Sullivan, P. F., & Posthuma, D. (2014) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2014.09.003 · Cited by 25
Curtis, D., Coelewij, L., Liu, S.-H., Humphrey, J., & Mott, R. (2018) · Behavior Genetics · doi:10.1007/s10519-018-9893-3 · Cited by 25
Curtis, D. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0272-6 · Cited by 25
Cottee, M. A., Letham, S. C., Young, G. R., Stoye, J. P., & Taylor, I. A. (2020) · Science Advances · doi:10.1126/sciadv.aay6354 · Cited by 25
Delorme, T. C., Srivastava, L. K., & Cermakian, N. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.030 · Cited by 25
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia
Maj, C., Minelli, A., Giacopuzzi, E., Sacchetti, E., & Gennarelli, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150514232745 · Cited by 24
Zhao, J., Liu, X., Huo, C., Zhao, T., & Ye, H. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.046 · Cited by 24
Adorján, I., Sun, B., Feher, V., Tyler, T., Veres, D. S., Chance, S. A., & Szele, F. G. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.581685 · Cited by 24
Kay, Y., Tsan, L., Davis, E. A., Tian, C., Décarie-Spain, L., Sadybekov, A., Pushkin, A. N., Katritch, V., Kanoski, S. E., & Herring, B. E. (2022) · Nature Communications · doi:10.1038/s41467-022-28430-5 · Cited by 24
Monoallelic and biallelic mutations inRELNunderlie a graded series of neurodevelopmental disorders
Donato, N. D., Guerrini, R., Billington, C. J., Barkovich, A. J., Dinkel, P., Freri, E., Heide, M., Gershon, E. S., Gertler, T. S., Hopkin, R. J., et al. (2022) · Brain · doi:10.1093/brain/awac164 · Cited by 24
Potential diagnostic biomarkers for schizophrenia
Yue, W., Huang, H., & Duan, J. (2022) · Medical Review · doi:10.1515/mr-2022-0009 · Cited by 24
Jiao, S., Cao, T., & Cai, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1005702 · Cited by 25
Kathuria, A., Lopez-Lengowski, K., Watmuff, B., & Karmacharya, R. (2023) · Genome Medicine · doi:10.1186/s13073-023-01203-5 · Cited by 24
The Future of Neuroepigenetics in the Human Brain
Mitchell, A., Roussos, P., Peter, C. J., Tsankova, N. M., & Akbarian, S. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00008-5 · Cited by 24
Self-citationGenome-wide burden of deleterious coding variants increased in schizophrenia
Loohuis, L. M. O., Vorstman, J. A. S., Ori, A. P. S., Staats, K. A., Wang, T., Richards, A. L., Leonenko, G., Walters, J., DeYoung, J. A., Kahn, R. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8501 · Cited by 24
Rare mutations and hypermethylation of the ARC gene associated with schizophrenia
Chuang, Y.-A., Hu, T., Chen, C., Hsu, S.-H., Tsai, H.-Y., & Cheng, M.-C. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.07.019 · Cited by 24
Buonaguro, E. F., Iasevoli, F., Marmo, F., Eramo, A., Latte, G., Avagliano, C., Tomasetti, C., & de Bartolomeis, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.012 · Cited by 24
Sungur, A. Ö., Schwarting, R. K. W., & Wöhr, M. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.038 · Cited by 24
Estimating contribution of rare non‐coding variants to neuropsychiatric disorders
Takata, A. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12774 · Cited by 24
Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophrenia
Gusev, F. E., Reshetov, D. A., Mitchell, A., Андреева, Т. В., Dincer, A., Grigorenko, A. P., Fedonin, G. G., Halene, T. B., Aliseychik, M., Filippova, E., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0596-1 · Cited by 24
Rosch, R. E., Burrows, D. R. W., Jones, L., Peters, C. H., Ruben, P. C., & Samarut, É. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00556 · Cited by 24
Mojarad, B. A., Yin, Y., Manshaei, R., Backstrom, I., Costain, G., Heung, T., Merico, D., Marshall, C. R., Bassett, A. S., & Yuen, R. K. C. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01211-2 · Cited by 24
Sleep maintains excitatory synapse diversity in the cortex and hippocampus
Koukaroudi, D., Qiu, Z., Fransén, E. A., Gokhale, R., Bulovaite, E., Komiyama, N. H., Seibt, J., & Grant, S. G. N. (2024) · Current Biology · doi:10.1016/j.cub.2024.07.032 · Cited by 23
Self-citationDe novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity
Nishi, A., Numata, S., Tajima, A., Zhu, X., Ito, K., Saito, A., Kato, Y., Kinoshita, M., Shimodera, S., Ono, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02792-z · Cited by 23
Developmental Profile of Psychiatric Risk Associated With Voltage-Gated Cation Channel Activity
Clifton, N. E., Collado‐Torres, L., Burke, E. E., Pardiñas, A. F., Harwood, J. C., Florio, A. D., Walters, J., Owen, M. J., O’Donovan, M. C., Weinberger, D. R., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.03.009 · Cited by 25
Self-citationYamamoto, K., Kuriu, T., Matsumura, K., Nagayasu, K., Tsurusaki, Y., Miyake, N., Yamamori, H., Yasuda, Y., Fujimoto, M., Fujiwara, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01676-1 · Cited by 23
Vatandoust, S. M., & Meftahi, G. H. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01982-3 · Cited by 23
Wan, R.-P., Liu, Z.-G., Huang, X., Kwan, P., Li, Y.-P., Qu, X.-C., Ye, X., Chen, F., Zhang, D., He, M., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac210 · Cited by 23
Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
Dubonyte, U., Asenjo-Martínez, A., Werge, T. M., Lage, K., & Kirkeby, A. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01460-2 · Cited by 23
Genetic insights into childhood-onset schizophrenia: The yield of clinical exome sequencing
Alkelai, A., Greenbaum, L., Shohat, S., Povysil, G., Malakar, A., Ren, Z., Motelow, J. E., Schechter, T., Draiman, B., Chitrit-Raveh, E., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2022.12.033 · Cited by 23
Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia
Bilecki, W., & Maćkowiak, M. (2023) · Genes · doi:10.3390/genes14020243 · Cited by 23
Sibarov, D. A., Tsytsarev, V., Volnova, A. B., Vaganova, A. N., Alves, J. M., Rojas, L. V., Sanabria, P., Ignashchenkova, A., Savage, E. D., & Inyushin, M. Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1201104 · Cited by 23
MicroRNA137-loaded lipid nanoparticles regulate synaptic proteins in the prefrontal cortex
Palumbo, M., Gautam, M., Sonneborn, A., Kim, K., Wilmarth, P. A., Reddy, A. P., Shi, X., Marks, D. L., Sahay, G., Abbas, A. I., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.08.016 · Cited by 23
An evolutionary perspective on complex neuropsychiatric disease
McClellan, J., Zoghbi, A. W., Buxbaum, J. D., Cappi, C., Crowley, J. J., Flint, J., Grice, D. E., Gülsüner, S., Iyegbe, C. O., Jain, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.10.037 · Cited by 25
Voltage‐gated calcium channels – from basic mechanisms to disease
Striessnig, J. (2016) · The Journal of Physiology · doi:10.1113/jp272619 · Cited by 23
Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability
Lalonde, J., Reis, S. A., Sivakumaran, S., Holland, C. S., Wesseling, H., Sauld, J. F. K., Alural, B., Zhao, W., Steen, J. A. J., & Haggarty, S. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01750-7 · Cited by 23
The DNA double-strand “breakome” of mouse spermatids
Grégoire, M.-C., Leduc, F., Morin, M., Cavé, T., Arguin, M., Richter, M. V., Jacques, P., & Boissonneault, G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2769-0 · Cited by 23
Salvoro, C., Bortoluzzi, S., Coppe, A., Valle, G., Feltrin, E., Mostacciuolo, M. L., & Vazza, G. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0922-2 · Cited by 23
Suddaby, J. S., Silver, J., & So, J. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000219 · Cited by 23
Murayama, T., & Kurebayashi, N. (2019) · Current Protocols in Pharmacology · doi:10.1002/cpph.71 · Cited by 23
Sawahata, M., Mori, D., Arioka, Y., Kubo, H., Kushima, I., Kitagawa, K., Sobue, A., Shishido, E., Sekiguchi, M., Kodama, A., et al. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12993 · Cited by 23
Axonal branch patterning and neuronal shape diversity: roles in developmental circuit assembly
Hoersting, A.-K., & Schmucker, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.10.019 · Cited by 23
Regulation of hippocampal excitatory synapses by the Zdhhc5 palmitoyl acyltransferase
Shimell, J. J., Globa, A. K., Sepers, M. D., Wild, A. R., Matin, N., Raymond, L. A., & Bamji, S. X. (2021) · Journal of Cell Science · doi:10.1242/jcs.254276 · Cited by 23
Sun, G., Lee, Y.-J., Lee, Y., Yu, H.-F., & Wang, D. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113444 · Cited by 23
O’Tuathaigh, C. M. P., Fumagalli, F., Desbonnet, L., Perez-Branguli, F., Moloney, G., Loftus, S., O’Leary, C., Petit, E., Cox, R., Tighe, O., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw120 · Cited by 22
Whole‐gene sequencing investigation ofSAT1in attempted suicide
Monson, E. T., de Klerk, K., Gaynor, S. C., Wagner, A. H., Breen, M. E., Parsons, M. G., Casavant, T. L., Zandi, P. P., Potash, J. B., & Willour, V. L. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32462 · Cited by 22
Vornholt, E., Luo, D., Qiu, W., McMichael, G. O., Liu, Y., Gillespie, N. A., Ma, C., & Vladimirov, V. I. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.015 · Cited by 23
Koromina, M., Flitton, M., Blockley, A., Mellor, I. R., & Knight, H. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-55635-4 · Cited by 22
ITSN1: a novel candidate gene involved in autosomal dominant neurodevelopmental disorder spectrum
Bruel, A., Vitobello, A., Thiffault, I., Manwaring, L. P., Willing, M. C., Agrawal, P. B., Bayat, A., Kitzler, T. M., Brownstein, C. A., Genetti, C. A., et al. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00985-9 · Cited by 22
de Bartolomeis, A., Vellucci, L., Simone, G. D., Mazza, B., Barone, A., & Ciccarelli, M. (2023) · Cells · doi:10.3390/cells12040574 · Cited by 22
Leone, R., Zuglian, C., Brambilla, R., & Morella, I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407865 · Cited by 22
Mäki‐Marttunen, T., Halnes, G., Devor, A., Witoelar, A., Bettella, F., Djurovic, S., Wang, Y., Einevoll, G. T., Andreassen, O. A., & Dale, A. M. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.002 · Cited by 22
Sungur, A. Ö., Stemmler, L., Wöhr, M., & Rust, M. B. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00025 · Cited by 22
Hlushchenko, I., Khanal, P., Abouelezz, A., Paavilainen, V. O., & Hotulainen, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00217 · Cited by 22
Pujol, C., Pellissier, L. P., Clément, C., Becker, J. A. J., & Merrer, J. L. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0247-y · Cited by 22
Chen, X., Duan, H.-F., Xiao, L., & Gan, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00565 · Cited by 22
Soczewka, P., Kołakowski, D., Rooij, I. I. S., Rzepnikowska, W., Ayscough, K. R., Kamińska, J., & Żołądek, T. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.036830 · Cited by 22
Hayata‐Takano, A., Kamo, T., Kijima, H., Seiriki, K., Ogata, K., Ago, Y., Nakazawa, T., Shintani, Y., Higashino, K., Nagayasu, K., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2468-18.2019 · Cited by 22
Evidence of association of the DISC1 interactome gene set with schizophrenia from GWAS
Facal, F., & Costas, J. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109729 · Cited by 22
The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia
Borgmann‐Winter, K. E., Wang, K., Bandyopadhyay, S., Torshizi, A. D., Blair, I. A., & Hahn, C.-G. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.025 · Cited by 22
Syndapin I Loss-of-Function in Mice Leads to Schizophrenia-Like Symptoms
Koch, N., Koch, D. C., Krueger, S., Tröger, J., Sabanov, V., Ahmed, T., McMillan, L. E., Wolf, D., Montag, D., Kessels, M. M., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa013 · Cited by 22
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders
Alkelai, A., Greenbaum, L., Docherty, A. R., Shabalin, A. A., Povysil, G., Malakar, A., Hughes, D., Delaney, S. L., Peabody, E. P., McNamara, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01383-9 · Cited by 22
Metadata
- Authors
- Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., Carrera, N., Humphreys, I., Johnson, J. S., Roussos, P., Barker, D. D., Banks, E., Milanova, V., Grant, S. G., Hannon, E., Rose, S. A., Chambert, K., Mahajan, M., Scolnick, E. M., Moran, J. L., Kirov, G., Palotie, A., McCarroll, S. A., Holmans, P., Sklar, P., Owen, M. J., Purcell, S. M., & O’Donovan, M. C.
- Affiliations
- Broad Institute (US)
- Cardiff University (GB)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- Medical University of Sofia (BG)
- University of Edinburgh (GB)
- Corresponding author
- Owen, Michael J.
- ORCID
- Fromer, Menachem
- Pocklington, Andrew J.
- Williams, Hywel J.
- Dwyer, Sarah
- Gormley, Padhraig
- Rees, Elliott
- Palta, Priit
- Ruderfer, Douglas M.
- Carrera, Noa
- Johnson, Jessica S.
- Roussos, Panos
- Banks, Eric
- Milanova, Vihra
- Grant, Seth G.
- Hannon, Eilis
- Rose, Samuel A.
- Scolnick, Edward M.
- Moran, Jennifer L.
- Kirov, George
- Palotie, Aarno
- McCarroll, Steven A.
- Holmans, Peter
- Sklar, Pamela
- Owen, Michael J.
- Purcell, Shaun M.
- O’Donovan, Michael C.
- Venue
- Nature
- Published
- 2014-01-22
- Volume
- 506
- Issue
- 7487
- Pages
- 179-184
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4237002
- OpenAlex
- W2023962370
- Cited by
- 1,617
- References
- 43
- Citations by year
- 2026: 39 · 2025: 68 · 2024: 64 · 2023: 91 · 2022: 114 · 2021: 134 · 2020: 127 · 2019: 168 · 2018: 149 · 2017: 193 · 2016: 186 · 2015: 164 · 2014: 120
- FWCI
- 168.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01BX002395)
- Wellcome Trust (089062, WT 098051, WT089062, 098051)
- Medical Research Council (MR/L010305/1)
- National Institute of Mental Health (P50MH066392, R01MH071681, R01MH099126)
- National Human Genome Research Institute (R01HG005827)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- schizophrenia, de novo mutations, synaptic proteins, glutamatergic synapses, activity-regulated cytoskeleton-associated protein, NMDA receptor, FMRP, actin filament dynamics, autism spectrum disorder, intellectual disability, neurodevelopmental disorders, synaptic efficacy
- MeSH terms
- Child Development Disorders, Pervasive, Cytoskeletal Proteins, Humans, Intellectual Disability, Models, Neurological, Mutation, Nerve Net, Nerve Tissue Proteins, Neural Pathways, Phenotype, RNA, Messenger, Schizophrenia, Substrate Specificity, Synapses, Receptors, N-Methyl-D-Aspartate, Fragile X Messenger Ribonucleoprotein 1, Exome, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
